TABLE 4.
P values of pair-wise comparison of fungal burden data for isolate 2 (nikkomycin Z MIC, 4 μg/ml)
Agents compared (mg/kg/dose) | Antigen
|
Quantitative cultureb
|
||
---|---|---|---|---|
Lung | Spleen | Lung | Spleen | |
Control to amphotericin B (2.0) | 0.0026 | 0.0010 | <0.0001 | |
Control to itraconazole (75) | NSa | 0.0369 | <0.0001 | |
Control to nikkomycin Z (100) | 0.0041 | 0.0004 | ||
Control to nikkomycin Z (20) | 0.0015 | 0.0038 | NS | |
Control to nikkomycin Z (5) | NS | NS | ||
Amphotericin B (2.0) to itraconazole (75) | NS | NS | <0.0001 | 0.0002 |
Amphotericin B (2.0) to nikkomycin Z (100) | NS | NS | NS | |
Amphotericin B (2.0) to nikkomycin Z (20) | NS | NS | <0.0001 | 0.0088 |
Amphotericin B (2.0) to nikkomycin Z (5) | NS | 0.0013 | ||
Itraconazole (75) to nikkomycin Z (100) | NS | NS | 0.0006 | |
Itraconazole (75) to nikkomycin Z (20) | 0.0305 | NS | 0.0078 | NS |
Itraconazole (75) to nikkomycin Z (5) | NS | NS | ||
Nikkomycin Z (100) to nikkomycin Z (20) | NS | NS | 0.0149 | |
Nikkomycin Z (100) to nikkomycin Z (5) | NS | 0.0005 | ||
Nikkomycin Z (20) to nikkomycin Z (5) | NS | 0.0089 |
NS, not significant (P > 0.05).
Blank cells indicate that no comparison was made due to an insufficient number of evaluable samples in the control or nikkomycin Z groups.